Results 141 to 150 of about 10,915 (160)

[Nlrp6 overexpression inhibits lipid synthesis to suppress proliferation of hepatocellular carcinoma cells by regulating the AMPK-Srebp1c axis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Huang C, Sun Y, Li W, Liu L, Wang W, Zhang J.   +5 more
europepmc   +1 more source

第12回富山肝臓セミナー : パネルディスカッション『C型肝炎のインターフェロン療法』 [PDF]

, 1997
富山医科薬科大学医学会
core   +1 more source

[High expression of UBE2S promotes progression of hepatocellular carcinoma by increasing cancer cell stemness]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Chen H, Li Z, Wang M, Lu L, Tang Q, Luo L.   +5 more
europepmc   +1 more source

[Sodium butyrate and sorafenib synergistically inhibit hepatocellular carcinoma cells possibly by inducing ferroptosis through inhibiting YAP]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
He H, Liu L, Liu Y, Chen N, Sun S.
europepmc   +1 more source

[Calenduloside E inhibits hepatocellular carcinoma cell proliferation and migration by down-regulating GPX4 and SLC7A11 expression through the autophagy pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Chen Q, Shang S, Lu H, Li S, Sun Z, Fan X, Qi Z.   +6 more
europepmc   +1 more source

Combination of serum alpha-fetoprotein, PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma: a meta-analysis. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Song H, Wang J, Zhang H, Wu Y, Wang K, Wang X, Xu X.   +6 more
europepmc   +1 more source

ドウミャク　ソクセンジュツ　トイウ　カンガン　ノ　アタラシイ　チリョウホウ　ニツイテ [PDF]

, 1982
中村, 仁信
core  

Deep learning-based radiomics allows for a more accurate assessment of sarcopenia as a prognostic factor in hepatocellular carcinoma. [PDF]

J Zhejiang Univ Sci B
Liu Z, Wu Y, Khan AA, Lun LU, Wang J, Chen J, Jia N, Zheng S, Xu X.   +8 more
europepmc   +1 more source

[Overexpression of LncRNA MEG3 promotes ferroptosis and enhances chemotherapy sensitivity of hepatocellular carcinoma cells to cisplatin]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhu Q, Huang B, Wei L, Luo Q.
europepmc   +1 more source

[Efficacy and safety of transcatheter arterial chemoembolization followed by hepatic arterial infusion chemotherapy combined with TKI and PD-1 inhibitors as first-line treatment for advanced hepatocellular carcinoma]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhang L, Liu X, Hu X, Wang J, Yu X, Li G, You H, Zhang Q, Zhang H.   +8 more
europepmc   +1 more source